Tumor Microenvironment in Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• Clear cell renal cell carcinoma (ccRCC) progression is linked to m6A RNA methylation and the tumor microenvironment (TME).
• The specific influence of m6A RNA methylation regulators on the TME in ccRCC was previously unclear.

Purpose of the Study:

• To comprehensively evaluate the impact of m6A RNA methylation regulators on the TME in ccRCC.
• To identify potential associations between m6A regulators, TME characteristics, and patient prognosis.

Main Methods:

• Utilized transcriptome data from The Cancer Genome Atlas (TCGA) for ccRCC.
• Applied consensus clustering based on m6A regulator expression to identify distinct patient clusters.
• Analyzed differentially expressed genes (DEGs), immune infiltration (CIBERSORT), and pathway enrichment (GO, KEGG).

Main Results:

• Identified significant differences in 15 m6A regulators between ccRCC and normal tissues.
• Two clusters emerged, with Cluster 1 showing better overall survival (OS), lower immune/ESTIMATE scores, higher HLA, and lower immune checkpoint molecule expression.
• Found significant differences in immune infiltration and Th1/IFNγ gene signatures between clusters, with 4,429 DEGs enriched in immune processes.

Conclusions:

• m6A RNA methylation regulators are integral to ccRCC development.
• These regulators exhibit a strong correlation with the tumor microenvironment, suggesting potential therapeutic targets.